Cargando…
Role of nanotechnology and gene delivery systems in TRAIL-based therapies
Since its identification as a member of the tumour necrosis factor (TNF) family, TRAIL (TNF-related apoptosis-inducing ligand) has emerged as a new avenue in apoptosis-inducing cancer therapies. Its ability to circumvent the chemoresistance of conventional therapeutics and to interact with cancer st...
Autores principales: | Naoum, George E, Tawadros, Fady, Farooqi, Ammad Ahmad, Qureshi, Muhammad Zahid, Tabassum, Sobia, Buchsbaum, Donald J, Arafat, Waleed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990059/ https://www.ncbi.nlm.nih.gov/pubmed/27594905 http://dx.doi.org/10.3332/ecancer.2016.660 |
Ejemplares similares
-
Journey of TRAIL from Bench to Bedside and its Potential Role in Immuno-Oncology
por: Naoum, George E., et al.
Publicado: (2017) -
MicroRNA-34a: A Versatile Regulator of Myriads of Targets in Different Cancers
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2017) -
Survivin a radiogenetic promoter for glioblastoma viral gene therapy independently from CArG motifs
por: Naoum, George E., et al.
Publicado: (2017) -
TRAIL and vitamins: opting for keys to castle of cancer proteome instead of open sesame
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2012) -
Nip the HPV encoded evil in the cancer bud: HPV reshapes TRAILs and signaling landscapes
por: Halim, Talha Abdul, et al.
Publicado: (2013)